Last reviewed · How we verify
Flucelvax Quadrivalent Influenza Vaccine
Flucelvax Quadrivalent Influenza Vaccine is a Biologic drug developed by Seqirus. It is currently in Phase 2 development. Also known as: Flucelvax Quadrivalent.
At a glance
| Generic name | Flucelvax Quadrivalent Influenza Vaccine |
|---|---|
| Also known as | Flucelvax Quadrivalent |
| Sponsor | Seqirus |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Opioid, HIV and Immune System (PHASE4)
- BPL-1357 Against H1N1 Influenza Virus Challenge (PHASE2)
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants (PHASE3)
- Influenza Vaccination Strategy for Patients With Hematologic Malignancy (PHASE3)
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (PHASE1)
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age (PHASE3)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flucelvax Quadrivalent Influenza Vaccine CI brief — competitive landscape report
- Flucelvax Quadrivalent Influenza Vaccine updates RSS · CI watch RSS
- Seqirus portfolio CI
Frequently asked questions about Flucelvax Quadrivalent Influenza Vaccine
What is Flucelvax Quadrivalent Influenza Vaccine?
Flucelvax Quadrivalent Influenza Vaccine is a Biologic drug developed by Seqirus.
Who makes Flucelvax Quadrivalent Influenza Vaccine?
Flucelvax Quadrivalent Influenza Vaccine is developed by Seqirus (see full Seqirus pipeline at /company/seqirus).
Is Flucelvax Quadrivalent Influenza Vaccine also known as anything else?
Flucelvax Quadrivalent Influenza Vaccine is also known as Flucelvax Quadrivalent.
What development phase is Flucelvax Quadrivalent Influenza Vaccine in?
Flucelvax Quadrivalent Influenza Vaccine is in Phase 2.
Related
- Manufacturer: Seqirus — full pipeline
- Also known as: Flucelvax Quadrivalent
- Compare: Flucelvax Quadrivalent Influenza Vaccine vs similar drugs
- Pricing: Flucelvax Quadrivalent Influenza Vaccine cost, discount & access